Clinical meaning of JAK2 V617F mutation in chronic myeloproliferative disorders – the first experience
<p>Background An acquired V617F mutation in the JAK2 gene was found to occur in most patients with polycythaemia vera (PV), and about a half of those with essential thrombocythaemia (ET) and chronic idiopathic myelofibrosis (CIMF). It is the first clonal marker that allows differentiation betw...
| Main Authors: | , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Slovenian Medical Association
2006-10-01
|
| Series: | Zdravniški Vestnik |
| Subjects: | |
| Online Access: | http://vestnik.szd.si/index.php/ZdravVest/article/view/2034 |